Investigating the effectiveness and safety of ginger in preventing nausea and vomiting

Evaluating the effectiveness and safety of ginger in preventing nausea and vomiting after cholecystectomy: a double-blind clinical trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190911044744N2

Enrollment

Registered

2023-11-25

Start date

2023-11-22

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of nausea and vomiting after surgery.

Interventions

Intervention 1: Intervention group: Receiving zintoma tablet 250 mg Goldaru factory ,Take two capsules orally one hour before cholecystectomy surgery to reduce nausea and vomiting after surgery. Inter

Eligibility

Sex/Gender

All

Age

16 Years to No maximum

Inclusion criteria

Inclusion criteria: Age 16 years and older - Admitted to Rahmon hospital in Yazd due to cholecystectomy - Not receiving antiemetic drugs - Not taking Zintoma drug in the past one month - No history of allergic reaction to oral ginger - Tolerating the use of oral drugs - Being admitted to the internal surgery department General for 2 days - informed consent of the patient or his legal guardian

Exclusion criteria

Exclusion criteria: Pregnancy or breastfeeding Receiving chemotherapy drugs

Design outcomes

Primary

Measure	Time frame
Prevention of severe nausea and vomiting. Timepoint: Two, four, six and twelve hours after surgery. Method of measurement: questionnaire.	—

Secondary

Measure	Time frame
Bleeding risk. Timepoint: 2-4-6-12 hours after the operation. Method of measurement: blood test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEhsan mirzaei

Yazd University of Medical Sciences

ehsan.mirzaei.1369@gmail.com+98 35 3820 3419

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026